JP2019520071A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520071A5
JP2019520071A5 JP2018565398A JP2018565398A JP2019520071A5 JP 2019520071 A5 JP2019520071 A5 JP 2019520071A5 JP 2018565398 A JP2018565398 A JP 2018565398A JP 2018565398 A JP2018565398 A JP 2018565398A JP 2019520071 A5 JP2019520071 A5 JP 2019520071A5
Authority
JP
Japan
Prior art keywords
responder
mir
hsa
subject
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018565398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520071A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/064496 external-priority patent/WO2017216206A1/en
Publication of JP2019520071A publication Critical patent/JP2019520071A/ja
Publication of JP2019520071A5 publication Critical patent/JP2019520071A5/ja
Pending legal-status Critical Current

Links

JP2018565398A 2016-06-14 2017-06-14 急性重症大腸炎の処置応答を予測するための方法 Pending JP2019520071A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16305715.1 2016-06-14
EP16305715 2016-06-14
PCT/EP2017/064496 WO2017216206A1 (en) 2016-06-14 2017-06-14 Methods for predicting acute severe colitis treatment response

Publications (2)

Publication Number Publication Date
JP2019520071A JP2019520071A (ja) 2019-07-18
JP2019520071A5 true JP2019520071A5 (https=) 2020-05-21

Family

ID=56321880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018565398A Pending JP2019520071A (ja) 2016-06-14 2017-06-14 急性重症大腸炎の処置応答を予測するための方法

Country Status (4)

Country Link
US (2) US11060147B2 (https=)
EP (1) EP3469098A1 (https=)
JP (1) JP2019520071A (https=)
WO (1) WO2017216206A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111257568A (zh) * 2020-02-24 2020-06-09 中国科学院昆明动物研究所 检测转铁蛋白表达量的试剂在制备肠道免疫耐受失衡疾病诊断试剂或试剂盒中的应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774339A (en) 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US5132432A (en) 1989-09-22 1992-07-21 Molecular Probes, Inc. Chemically reactive pyrenyloxy sulfonic acid dyes
US5433896A (en) 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5274113A (en) 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5248782A (en) 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5338854A (en) 1991-02-13 1994-08-16 Molecular Probes, Inc. Fluorescent fatty acids derived from dipyrrometheneboron difluoride dyes
US5187288A (en) 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
US6048616A (en) 1993-04-21 2000-04-11 Philips Electronics N.A. Corp. Encapsulated quantum sized doped semiconductor particles and method of manufacturing same
US5571018A (en) 1994-11-23 1996-11-05 Motorola, Inc. Arrangement for simulating indirect fire in combat training
US5690807A (en) 1995-08-03 1997-11-25 Massachusetts Institute Of Technology Method for producing semiconductor particles
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
US5830912A (en) 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US5696157A (en) 1996-11-15 1997-12-09 Molecular Probes, Inc. Sulfonated derivatives of 7-aminocoumarin
US5866366A (en) 1997-07-01 1999-02-02 Smithkline Beecham Corporation gidB
US6130101A (en) 1997-09-23 2000-10-10 Molecular Probes, Inc. Sulfonated xanthene derivatives
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6617583B1 (en) 1998-09-18 2003-09-09 Massachusetts Institute Of Technology Inventory control
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems
US6855202B2 (en) 2001-11-30 2005-02-15 The Regents Of The University Of California Shaped nanocrystal particles and methods for making the same
AU4701200A (en) 1999-05-07 2000-11-21 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US6225198B1 (en) 2000-02-04 2001-05-01 The Regents Of The University Of California Process for forming shaped group II-VI semiconductor nanocrystals, and product formed using process
US6306736B1 (en) 2000-02-04 2001-10-23 The Regents Of The University Of California Process for forming shaped group III-V semiconductor nanocrystals, and product formed using process
WO2001071044A1 (en) 2000-03-22 2001-09-27 Quantum Dot Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
JP2003535063A (ja) 2000-06-01 2003-11-25 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティー 放射線医薬としてのナノ粒子のバイオコンジュゲート
AU2001279185B2 (en) 2000-08-04 2005-07-07 Molecular Probes, Inc. Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
US6709929B2 (en) 2001-06-25 2004-03-23 North Carolina State University Methods of forming nano-scale electronic and optoelectronic devices using non-photolithographically defined nano-channel templates
EP1409240B1 (en) 2001-07-20 2012-05-09 Life Technologies Corporation Luminescent nanoparticles and methods for their preparation
EP1963531B1 (en) 2005-12-23 2011-09-21 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
US8986926B2 (en) 2005-12-23 2015-03-24 Nanostring Technologies, Inc. Compositions comprising oriented, immobilized macromolecules and methods for their preparation
US8415102B2 (en) 2007-04-10 2013-04-09 Nanostring Technologies, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
US8126690B2 (en) 2007-05-18 2012-02-28 The Regents Of The University Of Michigan Algorithms to predict clinical response, adherence, and shunting with thiopurines
EP2156191A2 (en) 2007-06-15 2010-02-24 Smithkline Beecham Corporation Methods and kits for predicting treatment response in type ii diabetes mellitus patients
US20110117111A1 (en) 2008-03-26 2011-05-19 Johns Hopkins University Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
US8519115B2 (en) 2008-08-14 2013-08-27 Nanostring Technologies, Inc. Stable nanoreporters
RU2011111748A (ru) * 2008-08-29 2012-10-10 Сентокор Орто Байотек Инк. (Us) Маркеты и способы анализа и лечения язвенного колита и сходных заболеваний с использованием панели из 20 генов
EP2622105A4 (en) * 2010-09-27 2014-03-05 Philadelphia Children Hospital COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF INFLAMMABLE ENDURANCE DISEASES
WO2012042516A2 (en) * 2010-09-29 2012-04-05 Mor Research Applications Ltd. Prognostic methods, compositions and kits for prediction of acute lymphoblastic leukemia (all) relapse
JP6396992B2 (ja) * 2013-04-05 2018-09-26 ヌメディー， インコーポレイテッド 消化器系疾患およびその他の疾患の処置

Similar Documents

Publication Publication Date Title
Mas et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma
Maluf et al. The urine microRNA profile may help monitor post-transplant renal graft function
Busk et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for< 12 h vs. 12–72 h
Soares et al. Dysbiotic bacterial and fungal communities not restricted to clinically affected skin sites in dandruff
Dolatabadi et al. Cell cycle and cell size dependent gene expression reveals distinct subpopulations at single-cell level
JP2016520192A5 (https=)
JP2018511611A5 (https=)
CA3075927A1 (en) Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
Yenerel et al. Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status
JP2017505140A5 (https=)
KR20190038935A (ko) 면역요법 마커들 및 그 용도들(immunotherapy markers and uses therefor)
JP2015511721A5 (https=)
CN106872338A (zh) 一种血液细胞稳定剂及其应用
Horkowitz et al. Acetylcholine regulates pulmonary pathology during viral infection and recovery
Roques et al. Detection of the CALR mutation in the diagnosis of splanchnic vein thrombosis.
Brillant et al. Dynamic and accurate assessment of acetaminophen-induced hepatotoxicity by integrated photoacoustic imaging and mechanistic biomarkers in vivo
Vangeti et al. Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndrome
JP2017528715A5 (https=)
Pedretti et al. Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
JP2013522589A5 (https=)
Gu et al. Tensions in taxonomies: current understanding and future directions in the pathobiologic basis and treatment of group 1 and group 3 pulmonary hypertension
Salem et al. Myeloma minimal residual disease testing in the United States: evidence of improved standardization
JP2020502498A5 (https=)
JP2019520071A5 (https=)
IL274279B2 (en) Predicting peptide receptor radiotherapy using a gene expression assay